Population Pharmacokinetic and Pharmacodynamic Modeling of Lusutrombopag, a Newly Developed Oral Thrombopoietin Receptor Agonist, in Healthy Subjects
Crossref DOI link: https://doi.org/10.1007/s40262-016-0411-6
Published Online: 2016-05-21
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Katsube, Takayuki
Ishibashi, Toru
Kano, Takeshi
Wajima, Toshihiro
Text and Data Mining valid from 2016-05-21